Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 6, 2011, Pages 506-511

  Haas, Fred J L M ^a   Kluft, Cornelis ^b   Biesma, Douwe H ^a,c   Schutgens, Roger E G ^c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

deep venous thrombosis; thrombin generation; thrombophilia

Indexed keywords

THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; CHROMOGENIC THROMBIN GENERATION ASSAY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBIN TIME; THROMBOPHILIA;

ACUTE-PHASE REACTION; CASE-CONTROL STUDIES; CHROMOGENIC COMPOUNDS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTHROMBIN TIME; RISK FACTORS; THROMBIN; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 80052089568     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328347404d     Document Type: Article

References (36)

1. Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008; 143:321-335.
2. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009; 35:695-710.
3. Wichers IM, Tanck MW, Meijers JC, Lisman T, Reitsma PH, Rosendaal FR, et al. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Thromb Haemost 2009; 101:465-470.
4. Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG. Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 2008; 6:104-110.
5. Chaireti R, Jennersjo C, Lindahl TL. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study. Thromb Res 2009; 124:178-184.
6. Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Thromb Haemost 2008; 99:223-228.
7. Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008; 99:767-773. (Pubitemid 351694233)
8. Eichinger S. Thrombin generation and venous thromboembolism. Hamostaseologie 2008; 28:37-39. (Pubitemid 351326257)
9. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper-and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32:249-253. (Pubitemid 37490547)
10. Tripodi A, Martinelli I, Chantarangkul V, Battaglioli T, Clerici M, Mannucci PM. The endogenous thrombin potential and the risk of venous thromboembolism. Thromb Res 2007; 121:353-359.
11. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost 2008; 6:1720-1725.
12. Brandts A, van Hylckama Vlieg A, Rosing J, Baglin TP, Rosendaal FR. The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C. J Thromb Haemost 2007; 5:416-418. (Pubitemid 46139470)
13. Eichinger S, Hron G, Kollars M, Kyrle PA. Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. Clin Chem 2008; 54:2042-2048. (Pubitemid 352774038)
14. Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 2006; 4:752-756.
15. Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost 2009; 7:1639-1648.
16. Tripodi A, Legnani C, Chantarangkul V, Cosmi B, Palareti G, Mannucci PM. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 2008; 6:1327-1333. (Pubitemid 352016312)
17. Tripodi A, Legnani C, Palareti G, Chantarangkul V, Mannucci PM. More on: high thrombin generation and the risk of recurrent venous thromboembolism. J Thromb Haemost 2009; 7:906-907.
18. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15. (Pubitemid 37449290)
19. Hemker HC, Al Dieri R, de Smedt E, Beguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96:553-561. (Pubitemid 44782533)
20. Sidelmann JJ, Bladbjerg EM, Gram J, Munster AM, Jespersen J. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis. Blood Coagul Fibrinolysis 2008; 19:405-409.
21. ten Cate-Hoek AJ, Dielis AW, Spronk HM, van Oerle R, Hamulyak K, Prins MH, ten Cate H. Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost, 2008; 100: 240-245.
22. Haas FJ, Schutgens RE, Kluft C, Biesma DH. A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly. Scand J Clin Lab Invest 2011; 71:12-18.
23. Schutgens RE, Ackermark P, Haas FJ, Nieuwenhuis HK, Peltenburg HG, Pijlman AH, et al. Combination of a normal D-dimer concentration and a nonhigh pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation 2003; 107:593-597. (Pubitemid 36176810)
24. Devreese K, Wijns W, Combes I, van Kerckhoven S, Hoylaerts MF. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis. Thromb Haemost 2007; 98:600-613. (Pubitemid 47412886)
25. Hezard N, Cornillet-Lefebvre P, Gillot L, Potron G, Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-A 20210 prothrombin gene and C-T 677 MTHFR gene mutations. Thromb Haemost 1998; 79:1054-1055.
26. Haas FJ, van Sterkenburg-Kamp BM, Scheepers HA. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies. Semin Thromb Hemost 1998; 24:355-362. (Pubitemid 28440712)
27. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Thromb Haemost 1995; 74:1597-1603. (Pubitemid 26018092)
28. Schambeck CM, Hinney K, Haubitz I, Mansouri TB, Wahler D, Keller F. Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21:289-292. (Pubitemid 32125380)
29. Lincz LF, Lonergan A, Scorgie FE, Rowlings P, Gibson R, Lawrie A, Seldon M. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden. Pathophysiol Haemost Thromb 2006; 35:435-439. (Pubitemid 46895717)
30. Elf JL, StrandbergK,Svensson PJ. The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis. J Thromb Thromb 2010; 29:465-470.
31. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyak K, Ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6:125-131.
32. Kluft C, Meijer P. External quality assessment for thrombin generation tests: an exploration. Semin Thromb Hemost 2010; 36:791-796.
33. Coppola A, Tufano A, Cerbone AM, Di MG. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 2009; 35:683-694.
34. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009; 113:5314-5322.
35. Nicolaides AN, Breddin HK, Carpenter P, Coccheri S,ConardJ,deStefano V, et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 2005; 24:1-26. (Pubitemid 43933045)
36. Olson JD. College of American Pathologists in Consensus Conference XXXVI: diagnostic issues in thrombophilia. Arch Pathol Lab Med 2002; 126:1277-1280. (Pubitemid 36237278)